Afatinib Dimaleate 50 mg Australia

Afatinib Dimaleate 50 mg is a targeted therapy used to treat certain EGFR mutation-positive non-small cell lung cancer (NSCLC). It works by blocking EGFR signals that help cancer cells grow and spread. Take one tablet once daily on an empty stomach, at least 1 hour before or 2 hours after meals. Common side effects include diarrhea, skin rash, mouth sores, and nail changes. Active Ingredient (Generic Name): Afatinib Dimaleate Indication: Non-small cell lung cancer Manufacturer: Boehringer Ingelheim India Pvt.Ltd Packaging: 7 tablets in 1 strip Strength 50mg Delivery Time: 6 To 15 days